GlassScriptPhysician profile
Marshall Haden
NPI 1538690391
$28,303.00
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $716 · 2021: $1,276 · 2022: $25K · 2023: $1,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $18,750.00 | 2022 | |
| Medinc of Texas | $4,850.05 | 2022 | |
| Smith+Nephew, INC. | $2,500.00 | 2022-2023 | |
| Medwest Associates | $1,937.66 | 2020-2021 | |
| Orthofix Medical, INC. | $158.52 | 2022 | |
| Innovation Technologies INC | $59.15 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $47.62 | 2021-2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Haden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.